Halozyme Therapeutics Incorporated
Halozyme Therapeutics Incorporate.../ US40637H1095 /
HALO
|
2024-09-20 10:00:00 PM
|
Chg.
-0.2600
|
Volume |
Bid1:10:16 AM |
Ask1:10:16 AM |
High |
Low |
|
59.2400USD
|
-0.44%
|
2.69 mill.
Turnover: 117.46 mill. |
59.2500Bid Size: 100 |
61.2000Ask Size: 1,200 |
59.8300 |
58.7100 |
Business description
Halozyme Therapeutics, Inc. is a platform biopharmaceutical company that researches, develops and markets proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan and worldwide. The company was founded in 1998 and is headquartered in San Diego, California.
Management board & Supervisory board
| CEO |
| Helen Torley |
| Management board |
| Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer |
| Supervisory board |
| Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley |
Company data
| Name: |
Halozyme Therapeutics Inc. |
| Address: |
12390 El Camino Real,San Diego, CA 92130 |
| Phone: |
+858 794 8889 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://halozyme.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
- |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
ir@halozyme.com
|
